Get started Log in

SLN — Silence Therapeutics News Story

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Market Cap
$928.86m
Enterprise Value
$856.81m
Revenue
$0.56m

Germany's Merck buys Silence Therapeutics for $1.3 billion

Silence Therapeutics

Mon 13:07

Germany's Merck buys Silence Therapeutics for $1.3 billionOct 19 (Reuters) - German drugmaker Merck KGaA MRCG.DE said on Monday it will acquire therapy developer Silence Therapeutics in an all-cash deal for about $1.3 billion.

 (Reporting by Christy Santhosh in Bengaluru; Editing by Devika Syamnath)
 ((Christy.Santhosh@thomsonreuters.com;))

Recent news on Silence Therapeutics

Silence Therapeutics more than doubles on $1.3 bln Merck KGaA buyout deal
Mon 14:01
Brief: Silence Therapeutics To Be Acquired By Merck KGaA
Mon 13:59
NASDAQ RESUMED AT 08:45 AM
Mon 13:45
Germany's Merck buys Silence Therapeutics in $1.3 billion RNA drug deal (updated)
Mon 13:18
Germany's Merck buys Silence Therapeutics for $1.3 billion
Mon 13:07